Soleno Therapeutics (SLNO) Cost of Revenue (2014 - 2026)
Soleno Therapeutics (SLNO) reported Cost of Revenue of $1.2 million for Q1 2026, up 38.82% on a QoQ basis from $863000.0 in Q4 2025.
Soleno Therapeutics (SLNO) has 6 years of Cost of Revenue data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Cost of Revenue changed N/A year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (changed N/A YoY) and the FY2025 annual result came in at $2.7 million, changed N/A from the prior year.
- Cost of Revenue rose to $1.2 million in Q1 2026 per SLNO's latest filing, from $863000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $1.2 million in Q1 2026 and bottomed at $696000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 64.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 392.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 296.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 207.52 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 863,000.00 |
| Dec 31, 2025 | 863,000.00 |
| Sep 30, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 696,000.00 |
| Jun 30, 2025 | 696,000.00 |
| Mar 31, 2017 | 27,000.00 |
| Mar 31, 2017 | 27,000.00 |
| Jun 30, 2016 | 51,000.00 |
| Jun 30, 2016 | 51,000.00 |
| Mar 31, 2016 | 461,000.00 |
| Mar 31, 2016 | 461,000.00 |
| Dec 31, 2015 | 1.64 Mn |
| Dec 31, 2015 | 1.64 Mn |
| Sep 30, 2015 | 467,000.00 |
| Sep 30, 2015 | 467,000.00 |
| Jun 30, 2015 | 22,000.00 |
| Jun 30, 2015 | 22,000.00 |
| Mar 31, 2015 | 18,000.00 |
| Mar 31, 2015 | 18,000.00 |
| Dec 31, 2014 | 156,359.00 |
| Dec 31, 2014 | 156,359.00 |
| Sep 30, 2014 | 84,000.00 |
| Sep 30, 2014 | 84,000.00 |
| Jun 30, 2014 | 12,000.00 |
| Jun 30, 2014 | 12,000.00 |